Total Funding
51
32
Total FundingSeries E raised
Growth Score
-42 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
108187
Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection.
- Surya Gadiraju: Vice President of Pharmaceutical Development and ManufacturingPast Role: Applied Materials, Team Member
- Sarah Walter: Vice President of Nonclinical Development
About the Company
Antiva Biosciences is a biopharmaceutical company developing novel, localized therapeutics for the treatment of diseases caused by HPV infection. They aim to prevent cancer by treating precancerous lesions caused by HPV. Their programs are in clinical trials for high-grade anal intraepithelial neoplasias (AIN 2,3) and high-grade cervical
intraepithelial neoplasias (CIN 2,3).
Women Led
